Filana Therapeutics, Inc. (NasdaqCM: FLNA)
Health Care · Pharmaceuticals · US
$0.82
-12.26% today · -78.2% 1Y
Filana Therapeutics, Inc. (NasdaqCM: FLNA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $39.46M and employs 19 people.
Over the last twelve months the share price has lost 78.2%, trading between 0.67 and 4.98.
Tweenvest scores Filana Therapeutics, Inc. across four factors: quality 36/100, value 34/100. Its strongest factor is quality.
FLNA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.46M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.88
- Dividend yield
- —
- Beta (5Y)
- -0.66
- 52-week high
- $4.98
- 52-week low
- $0.67
- Avg volume (3M)
- —
- Shares outstanding
- 48.31M
- Employees
- 19
- Next earnings
- —
About Filana Therapeutics, Inc.
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
- ISIN
- US14817C1071
- Founded
- 1998
- Listed since
- Jul 14, 2000
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hwail Pharmaceutical Co.,Ltd.KOSDAQ: A061250 | $40.68M | ₩6,500.00 | +2.36% |
| SCYNEXIS, Inc.NasdaqCM: SCYX | $40.59M | $4.08 | -20.31% |
| Herantis Pharma OyjHLSE: HRTIS | $39.83M | €1.34 | -5.36% |
| BF Biosciences LimitedKASE: BFBIO | $39.61M | PKRs124.18 | -0.40% |
| Incannex Healthcare Inc.NasdaqCM: IXHL | $38.89M | $3.10 | -3.13% |
| Rekah Pharmaceutical Industry Ltd.TASE: REKA | $38.83M | ₪10.42 | -11.39% |
| Jin Yang Pharmaceutical Co., Ltd.KOSDAQ: A007370 | $38.36M | ₩3,995.00 | +0.50% |
| InnoPharmax Inc.TPEX: 4172 | $38.33M | NT$10.25 | -3.76% |
Figures last refreshed Oct 11, 2026.